NCT05000931View on ClinicalTrials.gov

Osia 2 Pediatric Expansion Study

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

September 22, 2023

Study Completion Date

March 14, 2024

Conditions
Mixed Hearing LossSingle-Sided DeafnessConductive Hearing Loss
Interventions
DEVICE

Osia 2 System

Osia 2 System in a pediatric population aged 5 - 11 years by quantifying the type, frequency and severity of adverse events.

Trial Locations (7)

19104

Children's Hospital of Philadelphia, Philadelphia

44106

University Hospitals Cleveland Medical Center, Cleveland

55404

Children's Minnesota, Minneapolis

77030

Texas Children's Hospital, Houston

85013

Barrow Neurological Institute, Phoenix

92123

Rady Children's Hospital, San Diego

94304

Stanford University, Palo Alto

Sponsors

Lead Sponsor

Cochlear
All Listed Sponsors
collaborator

R. P. Chiacchierini Consulting, LLC

INDUSTRY

collaborator

Analytical Solutions Group, Inc.

UNKNOWN

lead

Cochlear

INDUSTRY

NCT05000931 - Osia 2 Pediatric Expansion Study | Biotech Hunter | Biotech Hunter